Skip to main content
OpenTrials
Completed

NCT Number: NCT05548517

TRE: Microbiome, Metabolic Health and Bone

In the Time-Restricted Eating: Microbiome and Bone (TREMBO) study, the primary goal is to determine the effect of time-restricted eating with caloric restriction compared to caloric restriction alone on bone health, as well as body weight and the gut microbiota in older women who are overweight or obese.

Completed

Looking for future studies?

Notify Me

Key information

Age range

50 year–79 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Rutgers University - NJ Inst Food Nutrition & Health

New Brunswick, New Jersey, 08901, United States

About this study

Time-restricted eating (TRE) has gained increased attention due to the possibility to induce weight loss and improve cardiometabolic health as a result of the purported alignment of circadian rhythm. However, since TRE is often reported to cause a spontaneous reduction of calories, it is not well understood if these health benefits are due to weight loss, circadian rhythm alignment, or a combination of the two. Furthermore, while weight loss can improve cardiometabolic health, it can also induce bone loss, which is problematic in older women who are at a higher risk of fracture. Interestingly, both bone turnover and the gut microbiota are responsive to diurnal variations, such as meal timing, and alterations in the gut microbiota have been associated with differences in bone health. In rodent models, caloric restriction can alter the gut microbiota composition with further alterations shown due to time-restricted eating. This suggests that time-restricted eating could affect bone health, which may be partially mediated by changes in the gut microbiota. Also, lifestyle patterns affects both the microbiota and bone. This randomized controlled trial will use behavior modification to examine TRE plus caloric restriction (CR) to achieve an evening energy deficit compared to CR alone on bone health, as well as body weight and the gut microbiota in older women who have overweight or obese.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Postmenopausal women (>2 years since last menses)
  • Body mass index (25-45 kg/m2)
  • Agree to be randomly assigned to consume food for ≤ 9 hours/day or ≥12 hours/day
  • Must attend on-site visits (about 10) in New Brunswick, NJ, USA (transportation/reimbursement for travel not included)

Exclusion criteria

  • Participants with >5% weight loss in the past 6 months or extreme dietary/physical activity habits
  • An inability to follow the experimental intervention or to perform the required specimen collections
  • Antibiotic use in the past 2 months
  • Current diagnosis, or history of cancer in past 3 years
  • History of surgical procedure for weight loss in the past 3 years
  • Current diagnosis or history of bone diseases, type I or II diabetes, gastrointestinal disease, hyperparathyroidism, untreated thyroid disease, significant immune, hepatic, cardiac, or renal disease
  • Uncontrolled hypertension or hyperlipidemia in abnormal ranges
  • Regular use of medications that affect bone metabolism, including bisphosphonates or hormone replacement.
  • A colonoscopy within the past 2 months
  • Alcohol or illicit drug abuse
  • Current smoker or having quit smoking in the past 3 months
  • Shift work
  • Participation in another clinical research trial which may interfere with the results of this study.

Treatment and study plan

time restricted eating (TRE)

Behavioral

9-hour eating window

Calorie Restriction

Behavioral

daily calorie restriction

Primary outcomes

  1. Bone mineral density (BMD - hip)

    Time frame: change from baseline to an average 6 months

    dual energy x-ray absorptiometry

Secondary outcomes

  1. Areal BMD (radius, lumbar spine)

    Time frame: change from baseline to an average 6 months

    dual energy x-ray absorptiometry

  2. Gut Microbiota

    Time frame: change from baseline to an average 6 months

    stool

  3. Weight loss

    Time frame: change from baseline to an average 6 months

    Body weight in kg

  4. Soft tissues

    Time frame: change from baseline to an average 6 months

    dual energy x-ray absorptiometry (lean, fat mass, visceral adipose tissue)

  5. Trabecular bone

    Time frame: Change from baseline to an average 6 months

    peripheral quantitative computed tomography (volumetric BMD, bone volume / total volume, and separation)

  6. Cortical (Ct) bone

    Time frame: change from baseline to an average 6 months

    peripheral quantitative computed tomography (Ct volumetric BMD, Ct thickness and porosity, and total BMD)

  7. Glucose - response to oral glucose tolerance test

    Time frame: change from baseline to an average 6 months

    fasting and response to glucose solution

  8. Insulin - response to oral glucose tolerance test

    Time frame: change from baseline to an average 6 months

    fasting and response to glucose solution

Other outcomes

  1. Fasting osteocalcin

    Time frame: change from baseline to an average 6 months

    serum bone formation and energy marker

  2. Fasting procollagen type 1 N-terminal propeptide (PINP)

    Time frame: change from baseline to an average 6 months

    serum bone formation marker

  3. Fasting C-telopeptide of type I collagen (CTX)

    Time frame: change from baseline to an average 6 months

    serum bone resorption marker

  4. Circumferences

    Time frame: change from baseline to an average 6 months

    tape measure (waist, hip and thigh)

  5. Short physical performance battery (SPPB)

    Time frame: change from baseline to an average 6 months

    Total score of SPPB (0-12; higher score is better)

  6. 6 minute walk test

    Time frame: change from baseline to an average 6 months

    total distance

  7. Timed up and go

    Time frame: change from baseline to an average 6 months

    total time

  8. Hand Grip

    Time frame: change from baseline to an average 6 months

    dynanometer (isometric grip force)

  9. Total body bone

    Time frame: Change from baseline to an average 6 months

    dual energy x-ray absorptiometry (BMD and BMC)

  10. Blood pressure (BP)

    Time frame: change from baseline to an average 6 months

    sphygmomanometer (systolic and diastolic BP)

  11. 25-hydroxyvitamin D (25OHD)

    Time frame: change from baseline to an average 6 months

    serum

  12. Parathyroid hormone (PTH)

    Time frame: change from baseline to an average 6 months

    serum

  13. estradiol

    Time frame: change from baseline to an average 6 months

    serum

  14. melatonin

    Time frame: change from baseline to an average 6 months

    serum

  15. cortisol

    Time frame: change from baseline to an average 6 months

    serum

  16. Cognitive function

    Time frame: change from baseline to an average 6 months

    Cambridge Neuropsychological Test Automated Battery (SOC, PAL, RTI, MTT)

  17. Quality of sleep

    Time frame: change from baseline to an average 6 months

    Pittsburgh sleep quality index (0-21; higher score is worse)

  18. Biomarkers of brain health

    Time frame: change from baseline to 6 months

    Serum amyloid-beta (42,40) and tau markers (217, 181), BDNF, NfL

  19. Diet quality score

    Time frame: change from baseline to an average 6 months

    nutrient analysis software (Healthy Eating Index 0-100; higher score is better)

  20. Eating self-efficacy

    Time frame: change from baseline to an average 6 months

    Weight lifestyle efficacy questionnaire short-form (0-80; higher score is better)

Sponsors and collaborators

Lead sponsor

Rutgers, The State University of New Jersey

Other

Registry information

Official study title

Time Restricted Eating on the Microbiome Affecting Metabolic Health and Bone in Older Women

Acronym: TREMBO

Important dates

Study start
2022
Primary completion
2024
Study completion
2025
First posted
Sep 21, 2022
Registry last updated
Apr 13, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.